Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 March 1996

The role of NMDA receptor complex in the regulation of emotional processes: looking for new forms of anxiety treatment

Maria Jessa-Jabłońska

Med Sci Monit 1996; 2(2): HY240-243 :: ID: 499761

Abstract

The vast preclinical literature indicates an anti-anxiety like profile of action of both competitive and non-competitive NMDA receptor complex antagonists. To clarify further the role of NMDA-related mechanisms in emotional control, it was of special interest to compare the effects of intraperitoneally injected different NMDA antagonists with diazepam, in two animal models of anxiety: the open field exploratory behaviour and the Vogel conflict test. Next, the results of repeated administration of diazepam, (+)-MK-801 (non-competitive NMDA antagonist) and CGP-37849 (competitive NMDA antagonist) were evaluated and compared with modifications in monoamine levels, in the striatum and limbic forebrain. The role of limbic structures i.e., the hippocampus and nucleus accumbens septi in the anxiolytic-like effects of (+)-MK-801 and AP7 (competitive NMDA antagonist) was also characterised. Overall, different NMDA antagonists appeared to showed an anxiolytic-like profile, similar to diazepam. Of all drugs examined, CGP-37849 seems to possess the best pharmacological profile and the largest distinction between the doses showing an anxiolytic-like action in the open field test, and changing rat motor behaviour. On repeated administration this drug not only retained its anxiolytic-like potency in the Vogel test, but even enhanced rat exploratory behaviour in a new environment. Nevertheless, positive clinical data need to support clear-cut preclinical results obtained with NMDA receptor complex antagonists.

Keywords: Anxiety, NMDA receptor complex antagonists, Diazepam, open field test, Vogel conflict test

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750